QIAGEN is the leading global provider of comprehensive solutions for the extraction of valuable molecular knowledge from biological specimens. Worldwide, QIAGEN serves 500.000 clients from molecular diagnostics (healthcare), applied testing (forensics, veterinary diagnostics and food safety), the pharmaceutical industry (pharmaceutical and biotechnology enterprises), and research (life sciences). QIAGEN has a staff of 4,300 employees at 35 locations.


Biotype Diagnostic GmbH
Biotype Diagnostic GmbH is a Dresden biotechnology enterprise with more than a decade of experience in the development, production, verification and marketing of testing systems in the field of DNA analytics. The molecular genetic solutions offered by Biotype Diagnostic set new standards in multi-parameter diagnostics and help to clarify medical questions at a genetic level. With a staff of 30, Biotype Diagnostic employs 18 in research and development.




Member of


Biotype Innovation GmbH is a member of the Molecular Diagnostics Group (MDG), a business association of companies focusing on biotechnology. Together with Biotype Diagnostic GmbH, Qualitype GmbH and ROTOP Pharmaka GmbH, the main object is to work interdisciplinary at developing innovative detection methods and diagnostics in the field of Life Science.